ATC
BMRN icon

Argent Trust Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

Argent Trust Co’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,454
Closed -$566K – 484
2020
Q4 		$566K Buy
6,454
+690
+12% +$54.7K 0.04% 299
2020
Q3 		$438K Buy
5,764
+2,142
+59% +$217K 0.04% 313
2020
Q2 		$447K Buy
3,622
+346
+11% +$34.4K 0.04% 305
2020
Q1 		$277K Sell
3,276
-640
-16% -$55.1K 0.03% 341
2019
Q4 		$331K Sell
3,916
-965
-20% -$72.9K 0.03% 366
2019
Q3 		$329K Buy
4,881
+615
+14% +$47.4K 0.03% 362
2019
Q2 		$365K Buy
4,266
+717
+20% +$61.3K 0.04% 335
2019
Q1 		$315K Buy
3,549
+516
+17% +$47.8K 0.03% 351
2018
Q4 		$258K Sell
3,033
-650
-18% -$61.8K 0.03% 370
2018
Q3 		$357K Sell
3,683
-38
-1% -$3.79K 0.04% 320
2018
Q2 		$349K Sell
3,721
-1,638
-31% -$143K 0.04% 327
2018
Q1 		$434K Sell
5,359
-851
-14% -$73K 0.12% 176
2017
Q4 		$554K Buy
6,210
+268
+5% +$23.3K 0.22% 136
2017
Q3 		$553K Sell
5,942
-309
-5% -$27.3K 0.22% 140
2017
Q2 		$568K Sell
6,251
-342
-5% -$31.1K 0.23% 133
2017
Q1 		$579K Sell
6,593
-1,025
-13% -$91.2K 0.24% 130
2016
Q4 		$631K Sell
7,618
-918
-11% -$78.9K 0.28% 112
2016
Q3 		$790K Sell
8,536
-257
-3% -$24.2K 0.34% 88
2016
Q2 		$684K Buy
8,793
+1,401
+19% +$119K 0.3% 98
2016
Q1 		$610K Buy
7,392
+23
+0.3% +$1.87K 0.3% 105
2015
Q4 		$772K Buy
7,369
+467
+7% +$48.8K 0.38% 79
2015
Q3 		$727K Sell
6,902
-32
-0.5% -$4.27K 0.41% 78
2015
Q2 		$948K Sell
6,934
-165
-2% -$20.4K 0.48% 63
2015
Q1 		$885K Buy
7,099
+480
+7% +$50.9K 0.45% 69
2014
Q4 		$598K Buy
+6,619
New +$550K 0.36% 88

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Argent Trust Co's BMRN Position: Q1 2021 in Review

Argent Trust Co sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2021, closing a stake of 6,454 shares — an estimated $566K sold.

Argent Trust Co first reported a position in BMRN in Q4 2014 and held it in 25 quarters. The position peaked at $948K in Q2 2015. 531 funds tracked by Wall St. Rank hold BMRN as of Q1 2021.

  • Argent Trust Co reported no remaining BioMarin Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Argent Trust Co sold 6,454 BioMarin Pharmaceuticals shares in Q1 2021, an estimated $566K.
  • Argent Trust Co first reported a position in BioMarin Pharmaceuticals in Q4 2014 and held it in 25 quarters.
  • Argent Trust Co's BioMarin Pharmaceuticals position peaked at $948K in Q2 2015.
  • 531 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2021.

Based on Argent Trust Co's 13F filing for Q1 2021, filed 12 May 2021.